search
Back to results

Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness

Primary Purpose

Psychosis, Schizophrenia

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
EMA
Sponsored by
Massachusetts General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Psychosis

Eligibility Criteria

18 Years - 55 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. 18-55 years old
  2. Experienced a psychotic disorder or mood disorder

Exclusion Criteria:

  1. Any neurological disorder or current substance use disorder (during the past 6 months)
  2. Not proficient in English
  3. A recent change in medication, or an acute symptom presentation
  4. Standard exclusion criteria for participation in an MRI scan (e.g., presence of metal in the body, claustrophobia, a history of head trauma).

Sites / Locations

  • Massachusetts General HospitalRecruiting

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Ecological Momentary Assessment

Arm Description

EMA collected daily (4x/day) for two weeks

Outcomes

Primary Outcome Measures

Trait level social isolation and loneliness
UCLA Loneliness Scale(20 and 4 item), Social Network Index, Social Anhedonia Scale, Penn facial affect recognition Task, Social Disconnectedness Scale, Social Provisions Scale
Characterize within-person, dynamic changes in objective isolation and loneliness
EMA questions derived from the UCLA Loneliness Scales, perceived discrimination scale
Psychosocial functioning
Quality of Life Scale, Cornblatt Global Functioning - Social and Role Scales
Physical health and cardiometabolic/immunological panel
Height, weight, waist circumference, systolic and diastolic blood pressure, blood oxygen level, heart rate, interleukin-6, TNF-alpha, Complete metabolic panel, lipid panel, C-reactive protein, Cortisol, CBC, HbA1c

Secondary Outcome Measures

Full Information

First Posted
June 18, 2021
Last Updated
October 17, 2023
Sponsor
Massachusetts General Hospital
Collaborators
Boston University
search

1. Study Identification

Unique Protocol Identification Number
NCT04940663
Brief Title
Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness
Official Title
Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
July 13, 2022 (Actual)
Primary Completion Date
June 2026 (Anticipated)
Study Completion Date
June 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Massachusetts General Hospital
Collaborators
Boston University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The proposed research will test the hypothesis that objective social isolation and loneliness are linked to neurobehavioral mechanisms involved in social perception and motivation in individuals with and without serious mental illness. Moreover, it will investigate the specific dynamic interactions among these experiences in daily life and how they, and their neurobehavioral predictors, are linked to day-to-day functioning. The findings of this project could provide novel targets for therapeutics aimed at improving functioning and overall quality of life in individuals with serious mental illnesses, as well as quantitative phenotypes for use in early detection efforts.
Detailed Description
Some of the most debilitating and harmful aspects of serious mental illnesses (SMI) are the 1) social isolation (low numbers of social contacts) and 2) the subjective experiences of social disconnection (loneliness) that frequently accompany these conditions. Social isolation and loneliness greatly impact day-to-day functioning and are associated with poor cardiometabolic health and early mortality in SMI, and currently there are no available treatments that can prevent or reverse these devastating consequences of having these illnesses. This may be in part because the neural and psychological mechanisms underlying social isolation and loneliness in SMI, and how they impact functioning and health outcomes, are poorly understood. However, recent clues from studies employing advanced neuroimaging and digital assessments have formed the basis of a novel approach to investigating such mechanisms, outlined in this proposal. Prior work has indicated that objective isolation and loneliness are correlated but also somewhat independent. Recent neuroimaging findings support this model, revealing that social isolation and loneliness have both shared and distinct neural correlates. However, it is also clear that these are not static phenomena; smartphone-based assessments have revealed transient, dynamic changes in social isolation and loneliness. Individual differences in the anticipation of rejection are associated with momentary experiences of loneliness, greater avoidance and subsequent increases in social isolation. Thus, in the current application, we propose to comprehensively measure both the relatively stable neural and behavioral predictors of social isolation and loneliness, as well as the moment-to-moment changes in these experiences, in 60 individuals with SMI and 60 control subjects. In Aim 1 of the proposed project, we will show that the higher levels of social isolation and loneliness in SMI are linked to shared and distinct neural responses to social stimuli, with deficient responses of social perception-related circuitry (medial temporal lobe regions) linked to social isolation, and deficient responses of reward-related circuitry (basal ganglia regions) linked to loneliness. In Aim 2, we will measure transient changes in social isolation and loneliness with smartphone assessments using a longitudinal "burst" design. Lastly, in Aim 3, we will determine how the quantitative markers of social isolation and loneliness identified in Aims 1 and 2 predict indices of real-world functioning, measuring the stability of these associations over time. Thus, in this project, we will show that fundamental neural and behavioral processes drive momentary variation in the experience of social isolation and loneliness, and directly impact functioning in SMI. In follow-up work, these findings can be used as objective targets in studies of novel interventions which aim to address these major causes of disability.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Psychosis, Schizophrenia

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
120 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Ecological Momentary Assessment
Arm Type
Other
Arm Description
EMA collected daily (4x/day) for two weeks
Intervention Type
Behavioral
Intervention Name(s)
EMA
Intervention Description
Participants will complete surveys about their feelings and social habits through a smartphone app (EMA)
Primary Outcome Measure Information:
Title
Trait level social isolation and loneliness
Description
UCLA Loneliness Scale(20 and 4 item), Social Network Index, Social Anhedonia Scale, Penn facial affect recognition Task, Social Disconnectedness Scale, Social Provisions Scale
Time Frame
6 months
Title
Characterize within-person, dynamic changes in objective isolation and loneliness
Description
EMA questions derived from the UCLA Loneliness Scales, perceived discrimination scale
Time Frame
6 months
Title
Psychosocial functioning
Description
Quality of Life Scale, Cornblatt Global Functioning - Social and Role Scales
Time Frame
6 months
Title
Physical health and cardiometabolic/immunological panel
Description
Height, weight, waist circumference, systolic and diastolic blood pressure, blood oxygen level, heart rate, interleukin-6, TNF-alpha, Complete metabolic panel, lipid panel, C-reactive protein, Cortisol, CBC, HbA1c
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 18-55 years old Experienced a psychotic disorder or mood disorder Exclusion Criteria: Any neurological disorder or current substance use disorder (during the past 6 months) Not proficient in English A recent change in medication, or an acute symptom presentation Standard exclusion criteria for participation in an MRI scan (e.g., presence of metal in the body, claustrophobia, a history of head trauma).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Daphne J Holt, MD, PhD
Phone
617-726-7618
Email
dholt@partners.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Daphne J Holt, MD, PhD
Organizational Affiliation
Massachusetts General Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Massachusetts General Hospital
City
Charlestown
State/Province
Massachusetts
ZIP/Postal Code
02129
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Daphne J Holt, MD, PhD
Phone
617-726-7618
Email
dholt@mgh.harvard.edu
First Name & Middle Initial & Last Name & Degree
Nicole DeTore, PhD
Phone
617-726-2065
Email
ndetore@mgh.harvard.edu

12. IPD Sharing Statement

Learn more about this trial

Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness

We'll reach out to this number within 24 hrs